Publication:
Efficacy of Apremilast for Oral Ulcers Associated With Active Behcet's Syndrome Over 64 Weeks: Results From A Phase III Study

dc.contributor.authorsHatemi, Guelen; Mahr, Alfred; Takeno, Mitsuhiro; Kim, Doyoung; Saadoun, David; Direskeneli, Haner; Cheng, Sue; Mccue, Shannon; Paris, Maria; Yazici, Yusuf
dc.date.accessioned2022-03-10T18:01:04Z
dc.date.accessioned2026-01-11T06:15:44Z
dc.date.available2022-03-10T18:01:04Z
dc.date.issued2020
dc.identifier.doidoiWOS:000513136300044
dc.identifier.eissn1610-0387
dc.identifier.issn1610-0379
dc.identifier.urihttps://hdl.handle.net/11424/222336
dc.identifier.wosWOS:000513136300044
dc.language.isoeng
dc.publisherWILEY
dc.relation.ispartofJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleEfficacy of Apremilast for Oral Ulcers Associated With Active Behcet's Syndrome Over 64 Weeks: Results From A Phase III Study
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.endPage21
oaire.citation.startPage20
oaire.citation.titleJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
oaire.citation.volume18

Files